BeStock  
Markets › Compare › AMPH vs ANIP

AMPH vs ANIP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AMPH · Amphastar Pharmaceuticals$25.54 ▼ 1.43%
ANIP · ANI Pharmaceuticals$71.93 ▲ 0.57%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

657993107121Oct 9, '25Apr 9, '26Oct 7, '26
  • AMPH +2.3%
  • ANIP -20.8%

Head to head

MetricAMPHANIP
Price$25.54$71.93
Change today▼ 1.43%▲ 0.57%
Market cap$1.09B$1.65B
Return, 3 months+34.3%-14.1%
Return, year to date-4.6%-8.9%
Return, 1 year-1.7%-21.5%
P/E (TTM)15.115.7
P/B1.42.8
P/E percentile vs own 5y45th62nd
Dividend yield––
Revenue growth (YoY, latest qtr)+5.4%+25.9%
Net profit growth (YoY)-2.2%+189.1%
Gross margin47.7%60.4%
Operating margin15.7%13.3%
Net margin10.8%10.2%
Return on equity10.3%19.3%
Analyst target vs. price-18.8%+45.8%
Analyst buy share0%71%
RSI (14)5943
30-day volatility33.5%27.4%
Max drawdown, 1 year-42.6%-26.4%
Trend readStrong uptrendStrong downtrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ANIP is the largest of the group by market value.
  • AMPH has returned the most over the past year.
  • AMPH carries the lowest trailing P/E.
  • ANIP is growing revenue fastest.
  • AMPH keeps the most profit per dollar of sales.
  • ANIP has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top